CAS: 140-11-4; Benzyl Acetate

相似化合物

100-51-6 2216-45-7 100-51-6

上下游产品

CAS号127-09-3 乙酸钠 | CAS号100-39-0 溴化苄 | CAS号64-19-7 冰醋酸 | CAS号100-51-6 苯甲醇 | CAS号108-24-7 乙酸酐 | CAS号100-44-7 氯化苄 | CAS号1363906-80-2 N5-acetyl-DBN*BPh4 | CAS号631-61-8 乙酸铵 | CAS号108-22-5 醋酸异丙烯酯 | CAS号935-04-6 乙烯基苯甲基醚 | CAS号506-96-7 乙酰溴 | CAS号618-32-6 苄氧基溴 | CAS号3433-80-5 邻溴溴苄 | CAS号5396-89-4 乙酰丙酮苄酯 | CAS号42998-51-6 丙二酸苄基乙酯 | CAS号946-33-8 2-苯甲基环己酮 | CAS号946-80-5 苄基苯基醚 | CAS号619-90-9 乙酸-4-硝基苄酯 | CAS号21388-97-6 3-硝基乙酸苄酯 | CAS号77376-01-3 2-nitrobenzyl a...

苯基丙酮置于thermobifida Fusca Phenylacetone Monooxygenase体系中,用 Aq. Phosphate Buffer,乙醇,水 用作溶剂,化学反应生成乙酸苄酯
参考文献:自然保持自然:用于合成香精醛和风味醛的两种新型化学酶一锅法级联反应
标题:自然保持自然:用于合成香精醛和风味醛的两种新型化学酶一锅法级联反应
摘要:人们非常需要基于绿色化学 12 项原则生产高价值化学品的新型合成策略.在本文中,我们提出了两种新型化学酶一锅法级联反应的概念验证,可用于生产有价值的香料和风味醛.我们使用可再生的苯基槐烯作为起始材料,例如丁香中的丁香酚或来自埃斯特拉贡的雌芪.对于第一种策略,进行 Pd 催化的烯丙基双键异构化和随后的酶介导的(芳香族双加氧酶,Ado)烯烃裂解以获得所需的醛.在第二条途径中,通过无铜 Wacker 氧化方案将双键氧化成相应的酮,然后进行酶促 Baeyer-Villiger 氧化(来自福氏嗜睡双歧杆菌的苯丙酮单加氧酶),酯酶介导的(来自荧光假单胞菌的酯酶,Pfei)水解和随后的伯醇氧化(来自恶臭假单胞菌的醇脱氢酶,Alkj) 添加到相应的醛类产物中.对八种不同的苯丙烯衍生物进行这些反应序列,允许在 4 个反应步骤后以高达 55% 的收率合成七种醛(每步为 86%).
Doi:10.1039/d3Gc04191C

专利信息

专利号:WO-2024105700-A1
优先权日:2022-11-18
标 题:A method for the synthesis of anthranilic amide compounds and intermediates thereof
发明人：MALVIYA NITIN; MAL SANJIB; KLAUSENER ALEXANDER G M
权利人:PI INDUSTRIES LTD
摘要:The present invention discloses a method for the synthesis of a compound of formula (V) or a salt thereof, wherein, R, R1, R2, R3, R4a and R4b are as defined in the detailed description. The method further comprises the synthesis of an anthranilic diamide compound of formula (Z).

专利号:US-4477594-A
优先权日:1982-12-16
标题 :Process for the synthesis of aliphatic alcohol-containing mixtures
发明人：GREENE MARVIN I; GELBEIN ABRAHAM P
权利人:CHEM SYSTEMS
摘要:A process for the synthesis of mixtures which include saturated aliphatic alcohols is disclosed. In the first step of the process, the first catalyst activation stage, a catalyst, which comprises the oxides of copper, zinc, aluminum, potassium and one or two additional metals selected from the group consisting of chromium, magnesium, cerium, cobalt, thorium and lanthanum, is partially activated. In this step, a reducing gas stream, which includes hydrogen and at least one inert gas, flows past the catalyst at a space velocity of up to 5,000 liters (STP) per hour, per kilogram of catalyst. The partially activated catalyst is then subjected to the second step of the process, second-stage catalyst activation. In this step, the catalyst is contacted by an activation gas stream comprising hydrogen and carbon monoxide present in a volume ratio of 0.5:1 and 4:1, respectively, at a temperature of 200 DEG to 450 DEG C. and a pressure of between 35 and 200 atmospheres. The activation gas flows at a space velocity of from 1,000 to 20,000 liters (STP) per hour, per kilogram of catalyst. Second-stage activation continues until the catalyst is contacted with at least 500,000 liters (STP) of activation gas per kilogram of catalyst. The fully activated catalyst, in the third step of the process, contacts a synthesis gas stream comprising hydrogen and carbon monoxide.

专利号:US-4938940-A
优先权日:1988-01-14
标 题:Vapor-phase method for synthesis of diamond
发明人：HIROSE YOICHI; KOMAKI KUNIO
权利人:HIROSE YOICHI; SHOWA DENKO KK
摘要:A method for vapor-phase synthesis of diamond comprises burning a raw material compound for synthesis of diamond thereby forming a combustion flame, disposing a substrate for deposition of diamond in said combustion flame, and keeping said substrate at a prescribed temperature, thereby inducing deposition of diamond on said substrate.

专利号:WO-03031376-A1
优先权日:2001-10-12
标 题 :Solid phase synthesis of substituted 1,5-benzodiazepine-2-one and 1,5-benzothiazepine-2-one
发明人：MORTON GEORGE C; SALVINO JOSEPH M; LABAUDINIERE RICHARD F; HERPIN TIMOTHY F
权利人:AVENTIS PHARMA INC; MORTON GEORGE C; SALVINO JOSEPH M; LABAUDINIERE RICHARD F; HERPIN TIMOTHY F
摘要:A solid phase synthetic method for making substituted 1,5-benzodiazepine-2-one or 1,5-benzothiazepine-2-one. The method is useful for synthesis of large numbers of compounds through automated parallel synthesis or combinatorial library generation and is thus important to rapid discovery or new therapeutic agents containing the base structure of 1,5-benzodiazepine-2-one or 1,5-benzothiazepine-2-one.

专利号:US-2004249114-A1
优先权日:2001-02-06
标题 :Methods of synthesis of polysuccinimide or polyaspartate by end capping polymerization
发明人：SWIFT GRAHAM; REDLICH GEORGE H; WEHBY JOHN NOLAN
摘要:Disclosed are methods of synthesis of homopolymers or copolymers containing succinimide or aspartate moieties formed in the presence of an end capping initiator. Also disclosed are methods of isolating, compounding, stabilizing and processing the homopolymers and copolymers.

专利号:US-2008125587-A1
优先权日:2006-05-25
标 题 :Synthesis of triazole compounds that modulate HSP90 activity
发明人：CHIMMANAMADA DINESH U; LEE CHI-WAN; JAMES DAVID; ZHANG SHIJIE; YING WEIWEN; CHAE JUNGHYUN; PRZEWLOKA TERESA
权利人:CHIMMANAMADA DINESH U; LEE CHI-WAN; JAMES DAVID; ZHANG SHIJIE; YING WEIWEN; CHAE JUNGHYUN; PRZEWLOKA TERESA
摘要:The present invention provides novel methods of preparing triazole compounds which inhibit the activity of Hsp90. One embodiment of the invention is directed to methods for preparing a triazole compound represented by the following Structural Formula: n n n n n n n n n n or a tautomer, a pharmaceutically acceptable salt, solvate, or clathrate, or a prodrug thereof, comprising the steps of: a) reacting an amide represented by the following Structural Formula: n n n n n n n n n n with a thionation reagent to form a thioamide; b) reacting the thioamide of step a) with hydrazine to form a hydrazonamide; c) reacting the hydrazonamide of step b) with a carbonylation or a thiocarbonylation reagent. n In one embodiment, the present invention is a method of synthesis of a compound of formula (IA) n n n n n n n n n n or a tautomer, a pharmaceutically acceptable salt, solvate, or clathrate, or a prodrug thereof, comprising reacting a compound of formula (IIA) n n n n n n n n n n with an oxidizing agent, thereby producing a compound of formula (IA). n The present invention is also directed to a method of preparing a compound or a tautomer thereof represented by the following Structural Formula: n n n n n n n n n n or a tautomer, a pharmaceutically acceptable salt, solvate, or clathrate, or a prodrug thereof. The method comprises the step of reacting a first starting compound represented by the following Structural Formula: n n n n n n n n n n in the presence of a mercuric salt, with a second starting compound represented by the following Structural Formula: